Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synaptogyrin-3 Mediates Presynaptic Dysfunction Induced by Tau
Joseph McInnes, Keimpe Wierda, An Snellinx, et al.
Neuron (2018) Vol. 97, Iss. 4, pp. 823-835.e8
Open Access | Times Cited: 203

Showing 1-25 of 203 citing articles:

Synergy between amyloid-β and tau in Alzheimer’s disease
Marc Aurel Busche, Bradley T. Hyman
Nature Neuroscience (2020) Vol. 23, Iss. 10, pp. 1183-1193
Closed Access | Times Cited: 869
Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease
Tiantian Guo, Denghong Zhang, Yuzhe Zeng, et al.
Molecular Neurodegeneration (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 712
Neuronal Cell Death Mechanisms in Major Neurodegenerative Diseases
Hao Ran, Hui-Yun Chang, Tzu‐Kang Sang
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 10, pp. 3082-3082
Open Access | Times Cited: 348
Microglia modulate neurodegeneration in Alzheimer’s and Parkinson’s diseases
Tim Bartels, Sebastiaan De Schepper, Soyon Hong
Science (2020) Vol. 370, Iss. 6512, pp. 66-69
Open Access | Times Cited: 312
The complexity of tau in Alzheimer’s disease
Nima Naseri, Hong Wang, Jennifer D. Guo, et al.
Neuroscience Letters (2019) Vol. 705, pp. 183-194
Open Access | Times Cited: 289
Phosphorylated tau interactome in the human Alzheimer’s disease brain
Eleanor Drummond, Geoffrey Pires, Claire MacMurray, et al.
Brain (2020) Vol. 143, Iss. 9, pp. 2803-2817
Open Access | Times Cited: 264
Synaptic degeneration in Alzheimer disease
Makis Tzioras, Robert I. McGeachan, Claire S. Durrant, et al.
Nature Reviews Neurology (2022) Vol. 19, Iss. 1, pp. 19-38
Closed Access | Times Cited: 259
The clinical promise of biomarkers of synapse damage or loss in Alzheimer’s disease
Martí Colom‐Cadena, Tara L. Spires‐Jones, Henrik Zetterberg, et al.
Alzheimer s Research & Therapy (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 251
A walk through tau therapeutic strategies
Santosh Jadhav, Jesús Ávila, Michael Schöll, et al.
Acta Neuropathologica Communications (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 248
Dendritic Tau in Alzheimer’s Disease
Arne Ittner, Lars M. Ittner
Neuron (2018) Vol. 99, Iss. 1, pp. 13-27
Open Access | Times Cited: 214
Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration
Tara E. Tracy, Jesús Madero‐Pérez, Danielle L. Swaney, et al.
Cell (2022) Vol. 185, Iss. 4, pp. 712-728.e14
Open Access | Times Cited: 211
Tau: Enabler of diverse brain disorders and target of rapidly evolving therapeutic strategies
Che-Wei Chang, Qiang Shao, Lennart Mucke
Science (2021) Vol. 371, Iss. 6532
Open Access | Times Cited: 194
Synaptic dysfunction in Alzheimer's disease: Mechanisms and therapeutic strategies
Yu Chen, Amy K.Y. Fu, Nancy Y. Ip
Pharmacology & Therapeutics (2018) Vol. 195, pp. 186-198
Closed Access | Times Cited: 183
Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation
Yijun Chen, Yang Yu
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 160
Amyloid Beta and Tau Cooperate to Cause Reversible Behavioral and Transcriptional Deficits in a Model of Alzheimer’s Disease
Eleanor K. Pickett, Abigail G. Herrmann, Jamie McQueen, et al.
Cell Reports (2019) Vol. 29, Iss. 11, pp. 3592-3604.e5
Open Access | Times Cited: 149
Neuronal cell death mechanisms in Alzheimer’s disease: An insight
Parul Goel, Sasanka Chakrabarti, Kapil Goel, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 132
The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases
Moxin Wu, Manqing Zhang, Xiaoping Yin, et al.
Translational Neurodegeneration (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 130
Synapse pathology in Alzheimer’s disease
Jessica Griffiths, Seth G. N. Grant
Seminars in Cell and Developmental Biology (2022) Vol. 139, pp. 13-23
Open Access | Times Cited: 115
Deregulated mitochondrial microRNAs in Alzheimer's disease: Focus on synapse and mitochondria
Prashanth Gowda, P. Hemachandra Reddy, Subodh Kumar
Ageing Research Reviews (2021) Vol. 73, pp. 101529-101529
Open Access | Times Cited: 107
Alzheimer’s disease as a synaptopathy: Evidence for dysfunction of synapses during disease progression
S. Meftah, Jian Gan
Frontiers in Synaptic Neuroscience (2023) Vol. 15
Open Access | Times Cited: 74
Neurotransmitters in Prevention and Treatment of Alzheimer’s Disease
Zhenqi Yang, Yong Zou, Lifeng Wang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3841-3841
Open Access | Times Cited: 52
Cellular and pathological functions of tau
C Bravo, Sarah Naguib, Li Gan
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 11, pp. 845-864
Closed Access | Times Cited: 39
Tau-mediated synaptic and neuronal dysfunction in neurodegenerative disease
Tara E. Tracy, Li Gan
Current Opinion in Neurobiology (2018) Vol. 51, pp. 134-138
Open Access | Times Cited: 112
Region-specific depletion of synaptic mitochondria in the brains of patients with Alzheimer’s disease
Eleanor K. Pickett, Jamie Rose, Caoimhe McCrory, et al.
Acta Neuropathologica (2018) Vol. 136, Iss. 5, pp. 747-757
Open Access | Times Cited: 108
The landscape of multiscale transcriptomic networks and key regulators in Parkinson’s disease
Qian Wang, Yuanxi Zhang, Minghui Wang, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 100
Page 1 - Next Page

Scroll to top